Browse Indicators

Operations
Indicator title
Presence of joint TB/HIV IEC materials in TB and HIV services
Number of health facilities that offer antiretroviral therapy (ART)
Districts providing antiretroviral combination therapy
Most-at-risk Populations: Reduction in HIV Prevalence
Number of reported congenital syphilis cases (live births and stillbirth) in the past 12 months
National index on policy related to young people and HIV/AIDS
Percentage of health facilities that provide HIV testing and counselling services
Health facilities providing comprehensive care referrals for HIV/AIDS care and support
National monitoring and evaluation capacity
Connection to a parent or primary caregiver
Number of people on opioid substitution therapy (OST)
Intensified TB case-finding among PLWHA
Percentage of ARV distribution nodes that report on inventory consumption, quality, losses and adjustments on a monthly basis (Still under development)
HIV prevalence among young pregnant women
Number of health facilities providing ANC services that also provide CD4 testing on site, or have a system for collecting and transporting blood samples for CD4 testing for HIV-infected pregnant women
Proportion of all registered TB patients who are tested and are HIV-positive
The percent of districts with at least one operational testing and counselling site
Availability of free condoms at TB services
Percentage of HIV-positive pregnant IDU women who received OST during pregnancy
HIV prevalence among pregnant women
Number and percentage of adults and children newly enrolled in HIV care who start on treatment for latent TB infection (isoniazid preventive therapy) among the total number of adults and children newly enrolled in HIV care over a given time period
Number of eligible adults and children who newly initiated antiretroviral therapy (ART) during the reporting period (2012)
Use of specified health services by young people
Percentage of women accessing antenatal care (ANC) services who were tested for syphilis at first ANC visit
Laboratory capacity to monitor antiretroviral combination therapy

Pages